An Approach to Factor Assays in Patients with Strong Lupus Anticoagulants

Abstract

Higb-titer lupus anticoqgulants (LACs) may present technical and diagnostic dffficulties in the evaluation of patients with specific factor deficiencies or inhibitors. These potent LACS, although infrequently encountered, may be very confusing because they do not generate the characteristic pattern of rising factor levels with increasing sample dilutions. In addition, they may prevent assessment of individual factor defects by lowering activities below detectable or evaluable levels (<1%). To help resolve these problems, our taboratory has developed an approach that incorporates a variation of the platelet neutralization procedure (PNP), wherein we add phospholipid (PL) to adsorb the LAC in each of the dilutions of the individual factor assays. Using factor VIII for the prototypic studies, we characterized three basic result patterns that might arise, depending on the amount of factor activity recovered. As observed in patients exhibiting two of these patterns, an appreciable increase in activity agrees with the neutralization of a LAC and provides evidence against a coexistent severe deficiency of that factor and presumptive evidence against a coexistent, strong specific factor inhibitor. Key .Words: Lupus anticoagulants-Factor assays-Factor inhibitors.

Get full access to this article

View all access options for this article.

References

Krikler SH , Carter CJ , Chonn A. , et al. Fatal bleeding in a patient with a non-specific PT and AM inhibitnr . Clin Lab Haematol 1992; 14:73.

Baudo F. , Redaelli R. , Pezzetti L. , et al. Prothrombin-antibody coexistent with lupus anticoagulant (LA): clinical study and immunochemical characterization. Thromb Res 1990;57:279.

Bernini JC , Buchanan GR , Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant . J Pediatr 1993;123:937.

Fleck RA , Rapaport SI , Rao VM Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512.

Harrison RL , Alperin JB , Kumar D. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use. Arch Pathol Lab Med 1987; 111:179.

Simel DL , St. Clair EW , Adams J. , et al. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombineniia syndrome. Am J Med 1987;83:563.

Ballard HS , Nyamuswa G. Life-threatening hemorrhage in a patient with rheumatoid arthritis and a lupus anticoagulant coexisting with acquired autoantibodies against factor VIII . Br J Rheumatol 1993;32:515.

Saxena R. , Dhot PS , Saraya AK , et al. Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant. Am J Hematol 1993;42:232.

Saxena R. , Saraya AK , Kotte VK , et al. Inosithin neutralization test to measure lupus anticoagulants . Am J Clin Pathol 1993 ;99:61.

10.

Triplett DA Laboratory diagnosis of lupus anticoagulants . Semin Thromb Hemost 1990;16:182.

11.

Clyne LP , Dainiak N. , Hoffman R. , et al. In vitro correction of anticoagulant activity and specific clotting factor assays in SLE. Thromb Res 1980;18:643.

12.

Clyne LP , Yen Y. , Kriz NS , et al. The lupus anticoagulant: high incidence of "negative" mixing studies in a human immunodeficiency virus-positive population. Arch Pathol Lab Med 1993; 117:595.

13.

Triplett D. , Brandt J. , Kaczor D. , et al. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678.

14.

Thiagarajan P. , Pengo V. , Shapiro S. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986;68:869.

15.

Rauch J. , Tannenbaum M. , Janoff AS Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989;62: 892.

16.

Green D. , Lechner K. A survey of 215 non-hemophiliac patients with inhibitors to factor VIII. Thromb Haemost 45:200, 1981.

17.

Chediak J. Lupus anticoagulants. In: Green D , ed. Anticoagulants: physiologic, pathologic, and pharmacologic . Boca Raton, FL: CRC Press, Inc. , 1994:143.